PARIS (Reuters) - Health authorities in some European countries are facing resistance to AstraZeneca's COVID-19 vaccine after side-effects led hospital staff and other front-line workers to call in ...
As countries in Europe and elsewhere continue to pause administration of the AstraZeneca COVID-19 vaccines over reports of clotting events in recipients, the European Medicines Agency (EMA) announced ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Pharmaceutical company AstraZeneca has initiated a global withdrawal of ...
Several LGUs have signed a deal with AstraZeneca. Learn more about how the Oxford-AstraZeneca COVID-19 vaccine was developed, its cost and efficacy, and some controversies about its clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results